Physician profile
Roberto Cervera
NPI 1215174024
$152,796.24
in general payments reported to CMS, 2019-2025
25 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $36K · 2021: $36K · 2022: $42K · 2023: $12K · 2024: $476 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $2,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,200.00 |
| Food and Beverage | $2,959.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $143,944.57 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Edwards Lifesciences Corporation | $4,224.82 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $1,600.18 | 2019-2024 | |
| Abiomed | $1,471.51 | 2019-2025 | Impella |
| Abbott Laboratories | $193.27 | 2019-2023 | Epic |
| Merck Sharp & Dohme LLC | $186.40 | 2020-2025 | Verquvo |
| W. L. Gore & Associates, INC. | $167.11 | 2022 | |
| Medtronic, INC. | $161.50 | 2021-2024 | Mosaic, Endurant Iis |
| Novartis Pharmaceuticals Corporation | $115.11 | 2019 | |
| Medtronic Vascular, INC. | $113.78 | 2019-2020 | |
| Intuitive Surgical, INC. | $96.89 | 2021 | |
| Baxter Healthcare | $90.00 | 2022 | |
| Corcym INC | $64.95 | 2024 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Impulse Dynamics (USA) INC. | $57.97 | 2024 | Optimizer |
| Teleflex LLC | $57.82 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $49.04 | 2021 | |
| Livanova USA, INC. | $33.23 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $29.64 | 2025 | Evkeeza |
| Boston Scientific Corporation | $24.24 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $23.12 | 2025 | Eliquis |
| Cagent Vascular INC | $21.45 | 2025 | Serrantor |
| Ethicon US, LLC | $19.37 | 2019 | |
| Biom'Up France Sas | $19.14 | 2021 | |
| Getinge USA Sales, LLC | $16.57 | 2023 | Cardioroot |
| Kiniksa Pharmaceuticals International, Plc | $14.56 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Cervera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.